The cure of one of the most frequent types of dementia: A historical parallel

Alzheimer Disease and Associated Disorders

Volumn 19, Issue 3, 2005, Pages 156-158

  Nitrini, Ricardo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; PENICILLIN G; TAU PROTEIN;

ANTIBIOTIC THERAPY; ARTICLE; CHRONIC INFLAMMATION; COGNITION; DEMENTIA; HISTORY; HUMAN; NERVE DEGENERATION; NEUROSYPHILIS; PARALYSIS; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; SYPHILIS; TREPONEMA PALLIDUM;

ALZHEIMER DISEASE; ANTI-BACTERIAL AGENTS; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; NEUROSYPHILIS; PENICILLINS; TREPONEMA PALLIDUM;

EID: 27544447384     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wad.0000174993.62494.fb     Document Type: Article

References (32)

1. Schaudinn F, Hoffmann E. Vorläufiger Bericht über das Vorkommen von Spirochaeten in syphilitischen Krankheitsprodukten und bei Papillomen. Arb Gesundh Amte. 1904/1905;22:527-534.
2. Duffy JD. General paralysis of the insane: neuropsychiatry's first challenge. J Neuropsychiatry Clin Neurosci. 1995;7:243-249.
3. Merritt HH, Adams RD, Solomon HC. Neurosyphilis. New York: Oxford University Press; 1946.
4. Hare EH. The origin and spread of dementia paralytica. J Ment Sci. 1959; 105:594-626.
5. World population prospects: the 2002 revision and urban prospects. United Nations Population Division, 2003. Available at: http://esa.un.org/unpp. Accessed September 28, 2004.
6. Mahoney JF, Arnold RC, Harris AD. Penicillin treatment of early syphilis: a preliminary report. Venereal Disease Information. 1943;24:355-357.
7. Moore M, Solomon HC. Contributions of Haslam, Bayle, and Esmarch and Jessen to the history of neurosyphilis. Arch Neurol Psychiatry. 1934; 32:804-839.
8. Brown EM. French psychiatry's initial reception of Bayle's discovery of general paresis of the insane. Bull Hist Med. 1994;68:235-253.
9. Fournier A. La Syphilis du Cerveau. Paris: Masson; 1879.
10. Nitrini R. The history of tabes dorsalis and the impact of observational studies in neurology. Arch Neurol. 2000;57:605-606.
11. Quétel C. History of Syphilis. Baltimore: The Johns Hopkins University Press; 1992.
12. Noguchi H, Moore JW. A demonstration of Treponema pallidum in the brain in cases of general paralysis. J Exp Med. 1913;17:232-239.
13. Ehrlich P, Hata S. La Chemiothérapie Expérimentale des Spirilloses. Paris: A. Maloine; 1911.
14. Dattner B, Thomas EW, Wexler G. The Management of Neurosyphilis. New York: Grune & Stratton; 1944.
15. Wagner-Jaureg J. Über die Einwirkung der Malaria auf die progressive paralyse. Psychiatr Neurol Wschr. 1918/1919;20:132-135.
16. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Neurology. 2001;56: 1143-1153.
17. Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie und Psychisch - Gerichtliche Medizin. 1907; 64:146-148.
18. Maurer K, Maurer U. Alzheimer: The Life of a Physician and the Career of a Disease. New York: Columbia University Press; 2003.
19. Alzheimer A. Histologische Studien zur Differentialdiagnose der progressiven Paralyse (Jena 1904).
20. Cited by Maurer K, Maurer U. Alzheimer: The Life of a Physician and the Career of a Disease. New York: Columbia University Press; 2003.
21. Hahn RD, Webster B, Weickhardt G, et al. The results of treatment in 1,086 general paralytics the majority of whom were followed for more than five years. J Chronic Dis. 1958;9:209-227.
22. Wassermann A, Neisser A, Bruck C. Eine serodiagnostische Reaktion bei Syphilis. Dtsch Med Wochenshr. 1906;32:745-746.
23. Petersen RC. Mild Cognitive Impairment. Oxford: Oxford University Press; 2003.
24. Coleman P, Federoff H, Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology. 2004;63: 1155-1162.
25. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging. 1997;18:351-357.
26. Morris JC, Price JL, McKeel DW Jr, et al. and the ANA Study group. The neuropathology of nondemented aging (abstract). Neurobiol Aging. 2004;25(suppl 2):S137.
27. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science. 2002;298: 789-791.
28. De Felice FG, Vieira MN, Saraiva LM, et al. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization. FASEB J. 2004;18:1366-1372.
29. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet. 1997;349:151-154.
30. Breteler MM. Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging. 2000;21:153-160.
31. Whitmer RA, Sidney S, Selby S, et al. Midlife cardiovascular risk factor and risk of dementia in late life. Neurology. 2005;64:277-281.
32. Mackay J, Mensah G. The Atlas of Heart Disease and Stroke. Available at: http://www.who.int/cardiovascular_diseases/en/. Geneva, WHO; 2005. Accessed April 27, 2004.